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Purpose of review: Pulmonary embolism remains one of the leading causes of
cardiovascular mortality. The wide range of reported mortality rates reflects
heterogeneity in comorbidity and severity of pulmonary embolism. Optimizing risk
stratification to prognose pulmonary embolism patients appears to be important to
improve management, treatment and clinical outcome.Recent findings:
Hemodynamic status is the most important short-term prognostic factor. High-risk
pulmonary embolism or massive pulmonary embolism is defined by the patient
response more than the clot size: patients with circulatory shock including sustained
hypotension should receive thrombolytic therapy in absence of contraindications.
Nonmassive or normotensive pulmonary embolism can be further stratified using
clinical features, imaging (echocardiography, computed tomography) and
biomarkers (troponins, natriuretic peptides): low-risk pulmonary embolism,
evaluated by clinical model (Pulmonary Embolism Severity Index; PESI) can
potentially be treated as outpatients; and intermediate-risk pulmonary embolism,
which can be further stratified into less-severe and more-severe intermediate risk.
The last may benefit from intensive clinical surveillance but the risk–benefit ratio for
thrombolysis has been inadequately quantified to make any strong recommendation.
New anticoagulants may transform traditional pulmonary embolism treatment.
Summary: Optimizing risk stratification of patients with normotensive pulmonary
embolism before they develop overt hemodynamic instability is the challenge of
current pulmonary embolism management. Treatment strategy has to integrate this
risk stratification and new anticoagulants arrival.
URL de la
notice http://okina.univ-angers.fr/publications/ua6488 [4]
DOI 10.1097/MCC.0b013e32835444bc [5]
Lien vers le
document http://dx.doi.org/10.1097/MCC.0b013e32835444bc [5]
Liens
[1] http://okina.univ-angers.fr/publications?f[author]=10242
[2] http://okina.univ-angers.fr/pierremarie.roy/publications
[3] http://okina.univ-angers.fr/publications?f[author]=10257
[4] http://okina.univ-angers.fr/publications/ua6488
[5] http://dx.doi.org/10.1097/MCC.0b013e32835444bc
Publié sur Okina (http://okina.univ-angers.fr)
